t(15;17)
About
Biomarker Type: Rearrangement
Present: True
Rearrangement Type: Translocation
Legacy biomarker representation, assumes GRCh37 / hg19 genome build.
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (2) | t(15;17) | APL with PML-RARA | Arsenic trioxide |